Humacyte Inc
NASDAQ:HUMA
Income Statement
Earnings Waterfall
Humacyte Inc
Revenue
|
0
USD
|
Operating Expenses
|
-100m
USD
|
Operating Income
|
-100m
USD
|
Other Expenses
|
-10.7m
USD
|
Net Income
|
-110.8m
USD
|
Income Statement
Humacyte Inc
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||
Revenue |
2
N/A
|
1
-36%
|
1
+4%
|
1
+6%
|
2
+46%
|
2
-11%
|
2
-10%
|
1
-15%
|
0
-98%
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||
Operating Expenses |
(74)
|
(76)
|
(82)
|
(81)
|
(84)
|
(87)
|
(86)
|
(87)
|
(94)
|
(95)
|
(100)
|
|
Selling, General & Administrative |
(16)
|
(18)
|
(21)
|
(22)
|
(22)
|
(23)
|
(23)
|
(22)
|
(23)
|
(23)
|
(23)
|
|
Research & Development |
(58)
|
(58)
|
(61)
|
(63)
|
(63)
|
(65)
|
(63)
|
(64)
|
(70)
|
(71)
|
(77)
|
|
Other Operating Expenses |
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(72)
N/A
|
(75)
-5%
|
(81)
-8%
|
(80)
+2%
|
(82)
-3%
|
(85)
-4%
|
(85)
+1%
|
(85)
-1%
|
(94)
-10%
|
(95)
-1%
|
(100)
-6%
|
|
Pre-Tax Income | ||||||||||||
Interest Income Expense |
(3)
|
(3)
|
(4)
|
(5)
|
(5)
|
(5)
|
(4)
|
(2)
|
(1)
|
(1)
|
(1)
|
|
Non-Reccuring Items |
3
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
Total Other Income |
0
|
(10)
|
56
|
59
|
116
|
124
|
76
|
59
|
6
|
5
|
(10)
|
|
Pre-Tax Income |
(71)
N/A
|
(85)
-19%
|
(26)
+69%
|
(26)
+2%
|
28
N/A
|
34
+22%
|
(12)
N/A
|
(29)
-143%
|
(89)
-205%
|
(89)
-1%
|
(111)
-24%
|
|
Net Income | ||||||||||||
Income from Continuing Operations |
(71)
|
(85)
|
(26)
|
(26)
|
28
|
34
|
(12)
|
(29)
|
(89)
|
(89)
|
(111)
|
|
Net Income (Common) |
(71)
N/A
|
(85)
-19%
|
(26)
+69%
|
(26)
+2%
|
28
N/A
|
34
+22%
|
(12)
N/A
|
(29)
-143%
|
(89)
-205%
|
(89)
-1%
|
(111)
-24%
|
|
EPS (Diluted) |
-0.7
N/A
|
-0.84
-20%
|
-0.26
+69%
|
-0.26
N/A
|
0.26
N/A
|
0.32
+23%
|
-0.12
N/A
|
-0.3
-150%
|
-0.87
-190%
|
-0.87
N/A
|
-1.07
-23%
|